Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of cancer
3.2.1.2 Continuous innovations in imaging and treatment technologies
3.2.1.3 Shift towards personalized treatment
3.2.2 Industry pitfalls & challenges
3.2.2.1 Significant costs associated with acquiring and maintaining advanced treatment planning systems
3.2.2.2 Stringent regulatory requirements and lengthy approval processes
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Component, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Advanced image processing systems
5.3 Treatment planning systems
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Oncology
6.3 Cardiology
6.4 Neurology
6.5 Orthopedics
6.6 Other applications
Chapter 7 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 MRI-based planning
7.3 CT-based planning
7.4 Radiation therapy
7.4.1 3D conformal radiation therapy
7.4.2 Intensity-modulated radiation therapy
7.4.3 Image-guided radiation therapy
7.4.4 Stereotactic body radiation therapy
7.5 Proton beam therapy
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Specialty clinics
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Accuray Incorporated
10.2 Agfa-Gevaert Group
10.3 Brainlab AG
10.4 Canon Medical Systems Corporation
10.5 C-RAD AB
10.6 Elekta AB
10.7 GE HealthCare Technologies Inc.
10.8 Hitachi, Ltd.
10.9 IBA Radiopharma Solutions
10.10 IntraOp Medical Corporation
10.11 Koninklijke Philips N.V.
10.12 Mercurius Health
10.13 Mirada Medical Limited
10.14 Siemens Healthineers AG
10.15 ViewRay, Inc.
